Pharmaceutical groups want more clarity on continuous manufacturing guideline
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)GlobalPharmaceuticalsProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/Policy